Morphine/pramipexole (Amalgent Therapeutics)

吗啡/普拉克索 (Amalgent Therapeutics)

Report date: 2025/10/28 17:50:50

Base Information

Drug NameMorphine/pramipexole (Amalgent Therapeutics)
Drug Alias NameAMGT-0220
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonistsDopamine D3 receptor agonistsMu opioid receptor agonists
TargetsDopamine D2 receptorDopamine D3 receptorMu opioid receptor
Therapy Area/IndicationsBehavior, AddictiveAcute Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesAmalgent Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesAmalgent Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsBehavior, AddictiveAcute Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A